Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury

Journal of Neurochemistry
Barry W FestoffBruce A Citron

Abstract

Minocycline, a clinically used tetracycline for over 40 years, crosses the blood-brain barrier and prevents caspase up-regulation. It reduces apoptosis in mouse models of Huntington's disease and familial amyotrophic lateral sclerosis (ALS) and is in clinical trial for sporadic ALS. Because apoptosis also occurs after brain and spinal cord (SCI) injury, its prevention may be useful in improving recovery. We analyzed minocycline's neuroprotective effects over 28 days following contusion SCI and found significant functional recovery compared to tetracycline. Histology, immunocytochemistry, and image analysis indicated statistically significant tissue sparing, reduced apoptosis and microgliosis, and less activated caspase-3 and substrate cleavage. Since our original report in abstract form, others have published both positive and negative effects of minocycline in various rodent models of SCI and with various routes of administration. We have since found decreased tumor necrosis factor-alpha, as well as caspase-3 mRNA expression, as possible mechanisms of action for minocycline's ameliorative action. These results support reports that modulating apoptosis, caspases, and microglia provide promising therapeutic targets for preventio...Continue Reading

References

Apr 1, 1985·Experimental Neurology·L J Noble, J R Wrathall
Nov 14, 1994·Annals of the New York Academy of Sciences·W YoungS Constantini
Oct 1, 1996·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H K WolfI Blümcke
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A R AminS B Abramson
Jul 11, 1997·Neuroscience Letters·B A CitronB W Festoff
Jan 24, 1998·Experimental Neurology·M S BeattieW Young
May 20, 1998·Journal of Molecular Neuroscience : MN·I V SmirnovaB W Festoff
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
Jul 30, 1999·Nature Medicine·J E SpringerP E Knapp
Oct 3, 1999·Experimental Neurology·K L BrewerR P Yezierski
Jan 5, 2000·Physiological Reviews·D G Nicholls, S L Budd
Mar 25, 2000·Neurochemistry International·Y L LeeL F Eng
Nov 4, 2000·Journal of Neurotrauma·B A Eldadah, A I Faden
Nov 4, 2000·Journal of Neurotrauma·M S BeattieJ C Bresnahan
Mar 22, 2001·Experimental Neurology·S D GrossmanJ R Wrathall

❮ Previous
Next ❯

Citations

May 15, 2008·Experimental Brain Research·Thao X HoangLeif A Havton
Jun 28, 2011·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Peter I JoyceAbraham Acevedo-Arozena
Apr 24, 2009·The Cerebellum·M T ViscomiM Molinari
Mar 5, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Swapan K RayNaren L Banik
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·David J Loane, Kimberly R Byrnes
Aug 13, 2011·Cell Death and Differentiation·J L VeneroB Joseph
May 24, 2011·Journal of Neurotrauma·Theda Marie Anne BoekhoffVeronika Maria Stein
Jun 20, 2012·Journal of Neurotrauma·Krishna Kumar VeeravalliJasti S Rao
Apr 17, 2012·Brain : a Journal of Neurology·Steven CashaR John Hurlbert
Mar 10, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eiron CudabackC Dirk Keene
Aug 13, 2009·Developmental Neuroscience·Zinaida S Vexler, Midori A Yenari
Jun 30, 2012·Journal of Neuroinflammation·Maria Nikodemova, Jyoti J Watters
Sep 25, 2012·Journal of Neuroinflammation·Seok Joon WonSang Won Suh
Oct 1, 2011·PloS One·Mari KitayamaToshihide Yamashita
Jun 1, 2008·Biologics : Targets & Therapy·Masaki Ueno, Toshihide Yamashita
Sep 3, 2011·Surgical Neurology International·Manoel Baldoino Leal-Filho
Jul 16, 2014·Experimental Neurology·Jason R PlemelDavid P Stirling
Jan 21, 2014·Molecular Neurobiology·Maria Teresa Viscomi, Marco Molinari
Oct 14, 2009·Expert Opinion on Biological Therapy·Ofer SadanDaniel Offen
Jul 27, 2014·Expert Opinion on Drug Discovery·Barry W Festoff
Feb 9, 2016·Journal of Cardiothoracic and Vascular Anesthesia·Benjamin DrengerYair Barzilay
Oct 23, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·N Garrido-MesaJ Gálvez
Jan 8, 2016·Brain Research·Sarah HellewellMaria Cristina Morganti-Kossmann
Jun 26, 2012·Brain, Behavior, and Immunity·Alok Kumar, David J Loane
Jul 19, 2011·Biotechnology Advances·Anna Maria ColangeloMichele Papa
May 25, 2011·Pharmacology & Therapeutics·Alexander G RabchevskyJoe E Springer
Jun 7, 2011·Pharmacology & Therapeutics·Chihiro Tohda, Tomoharu Kuboyama
Jul 9, 2010·Progress in Neurobiology·Elisabetta Polazzi, Barbara Monti
Apr 1, 2010·Experimental Neurology·M T ViscomiM Molinari
Nov 4, 2008·Behavioural Brain Research·Hye-Sun Kim, Yoo-Hun Suh
Feb 19, 2008·Neuroscience Letters·Kamila SaganováIvo Vanický
Mar 25, 2008·Experimental Neurology·Radmila Filipovic, Nada Zecevic
Sep 8, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shushi KabuVinod Labhasetwar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
David P StirlingWolfram Tetzlaff
Proceedings of the National Academy of Sciences of the United States of America
Yang D TengRobert M Friedlander
Proceedings of the National Academy of Sciences of the United States of America
J YrjänheikkiJ Koistinaho
© 2022 Meta ULC. All rights reserved